Skip to content

Certipharm

Active Private limited companyfounded 2020active for 6 yearsMolenbaan 50, 2290 VorselaarKBO/BCE: BE 0754.702.164

Timeline

11 events since 2020

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed NBBmicro format · 14 days late
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0754702164
Annual accounts 2024 filed PDFmicro format · 18 days late
2024
Weakest financial year net €59,104 ▼43.4% The net result drops to €59,104, the lowest from 2021 to 2025. It recovers the following year.
Annual accounts 2023 filed PDFmicro format · 156 days before the deadline
2023
Equity above €200,000 equity €295,929 ▲53.7% With a profit in every financial year since 2021, equity grows to €295,929.
Annual accounts 2022 filed PDFmicro format · on the deadline day
2022
Equity above €150,000 equity €192,580 ▲66.7% With a profit in every financial year since 2021, equity grows to €192,580.
Annual accounts 2021 filed PDFmicro format · 5 days before the deadline
2020
IncorporationFounding capital of €2,000, 2,000 shares · Founded by · appointed as director · published on 24-09-20204 points ▸
  • Founded by
  • The founding capital is €2,000, divided into 2,000 shares
  • holds 2,000 shares
  • appointed as director

Open the deed in the Belgian Official Gazette

First establishment Molenbaan 50, Vorselaar

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 22 September 2020, Certipharm was incorporated as a private limited company by one private individual, with a starting capital of €2,000.12 is director of the company, appointed by deed of 24-09-2020.2 Total assets went from €138,033 in 2021 to €157,372 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 24-09-2020
  3. 3National Bank, annual accounts 2021 and 2025

Next steps